Outsourcing

Scaling Up Fast

Best practices for scaling up manufacturing under a short deadline.

Manufacturing Materials for Clinical Trials. Image: JHDT Productions - stock.adobe.com

Accelerating Clinical Trial Materials

Flexible, adaptable processes speed the manufacture of investigational drug products.

Selecting the Right-Fit Partner for Biotherapeutic Development. Image: A. Hartung/STOCK.ADOBE.COM

Making the Best Match

Communication and transparency help foster strong manufacturing partnerships.

Collaboration Takes Cell and Gene Therapies Closer to Their Full Potential. Image: warut - Stock.adobe.com

Collaboration toward Commercialization

Innovators, contractors, and technology providers advance cell and gene therapies.

Demonstrating the Value of Collaboration

March 02, 2021

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.

Meeting CGT Demand

March 02, 2021

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

March 01, 2021

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

Avid Bioservices Expands Biologics Manufacturing Capacity

February 22, 2021

The second phase of the Myford facility expansion in California will add upstream and downstream processing suites.

Wavelength Pharmaceuticals Acquires Vanamali Organics

February 18, 2021

The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.

Cascade Chemistry Expands API Manufacturing Capacity

February 18, 2021

Cascade began production on new facilities to manufacture APIs for clinical and commercial GMP production.

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.

Quotient Sciences Acquires CDMO Arcinova

February 17, 2021

The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.

Avid Bioservices Enters Manufacturing Agreement with Humanigen for Lenzilumab

February 04, 2021

The CGMP manufacturing agreement will expand production of lenzilumab, a candidate for COVID-19 therapy, to support a potential emergency use authorization filing.

PathoQuest Joins CAACB Consortium as Viral Safety Expert

February 04, 2021

PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.